Utah Medical Products Inc 8-K Filing
Ticker: UTMD · Form: 8-K · Filed: Nov 4, 2025 · CIK: 706698
| Field | Detail |
|---|---|
| Company | Utah Medical Products Inc (UTMD) |
| Form Type | 8-K |
| Filed Date | Nov 4, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $58.10, $7,650 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Utah Medical Products Inc (ticker: UTMD) to the SEC on Nov 4, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $58.10 (stock options with an exercise price of $58.10 per share that will vest over a four-ye); $7,650 (e the UTMD standard Board Member fee of $7,650 per quarter, which will be pro-rated fo).
How long is this filing?
Utah Medical Products Inc's 8-K filing is 2 pages with approximately 683 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 683 words · 3 min read · ~2 pages · Grade level 9.9 · Accepted 2025-11-04 13:42:34
Key Financial Figures
- $58.10 — stock options with an exercise price of $58.10 per share that will vest over a four-ye
- $7,650 — e the UTMD standard Board Member fee of $7,650 per quarter, which will be pro-rated fo
Filing Documents
- utmd-20251104_8k.htm (8-K) — 26KB
- utmd_ex99z1.htm (EX-99.1) — 3KB
- 0001096906-25-001733.txt ( ) — 148KB
- utmd-20251104_def.xml (EX-101.DEF) — 2KB
- utmd-20251104_lab.xml (EX-101.LAB) — 20KB
- utmd-20251104_pre.xml (EX-101.PRE) — 13KB
- utmd-20251104.xsd (EX-101.SCH) — 2KB
- utmd-20251104_8k_htm.xml (XML) — 2KB
01—OTHER EVENTS
ITEM 8.01—OTHER EVENTS On November 4, 2025, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.31 per share is payable on January 5, 2026 to shareholders of record at the close of business on December 16, 2025. A copy of the press release is attached hereto as Exhibit 99.1.
01—FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS The following is filed as an exhibit to this report: Exhibit Number* Title of Document Location Item 99.1 Utah Medical Products, Inc. Appoints Director and Increases Quarterly Cash Dividend This filing _______________________________________ * All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. Dated: November 4, 2025 By: /s/ Kevin L. Cornwell Kevin L. Cornwell, Chief Executive Officer